Wolfe Research analyst Justin Lake downgrades Cano Health (NYSE:CANO) from Outperform to Peer Perform.
The Latest Analyst Ratings for Enanta Pharma
Within the last quarter, Enanta Pharma (NASDAQ:ENTA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…